Ordering
Available Variants5 mg
CHA.39223-5mg
Price
€72.08
Available – Dispatch in 14 days
25 mg
CHA.39223-25mg
Price
€270.40
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 mg | CHA.39223-5mg | €72.08 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
25 mg | CHA.39223-25mg | €270.40 |
≥98% (HPLC), powder, tankyrase inhibitor
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C14H11F3N2OS |
|---|---|
| CAS Number | 284028-89-3 |
| Molecular Weight | 312.31 |
| UNSPSC Code | 12352200 |
| PubChem Substance ID | 329830802 |
| NACRES | NA.77 |
| MDL number | MFCD16879017 |
| Assay | ≥98% (HPLC) |
| Form | powder |
| Quality level | 100 |
Safety Information Handling visibility
| pictograms |
GHS07
 GHS07
|
|---|---|
| signalword | Warning |
| hcodes | H302 |
| pcodes | P264 - P270 - P301 + P312 - P501 |
| Hazard Classifications | Acute Tox. 4 Oral |
| Storage Class | 11 - Combustible Solids |
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
XAV939, with a CAS number of 284028-89-3, is a small molecule inhibitor that has been identified as a potent suppressor of the Wnt/β-catenin signaling pathway. This pathway plays a critical role in various cellular processes, including cell proliferation, differentiation, and survival. XAV939 acts by inhibiting tankyrase, an enzyme that is involved in the regulation of axin, a key component of the Wnt/β-catenin signaling complex. By inhibiting tankyrase, XAV939 increases the levels of axin, leading to the degradation of β-catenin and subsequent suppression of Wnt/β-catenin signaling. This compound has been used as a research tool to study the Wnt/β-catenin pathway and its role in various diseases, including cancer and osteoporosis, and has shown promise as a potential therapeutic agent for the treatment of these diseases. Its mechanism of action makes it a valuable tool for understanding Wnt/β-catenin signaling.
